10 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 41.9% per year over the past 5 years.
Net income has grown slower than revenue (38.0% vs 41.9% per year).
Operating margin has contracted, at 12.1% in the latest year.
Financial health
The company holds more cash ($757M) than total debt ($288M).
Total debt has grown in line with revenue (44.5% vs 41.9% per year).
Operating income covered interest expense 16× in the latest year.
Total debt is 2.3× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$901M
$94M
44.4%
12.1%
6.4%
3.3%
-$67M
$288M
$757M
2024
$782M
$104M
50.1%
19.3%
11.5%
5.6%
$70M
$183M
$407M
2023
$558M
$77M
49.5%
17.2%
10.1%
5.2%
-$137M
$92M
$182M
2022
$389M
$39M
47.2%
15.2%
5.8%
3.2%
-$153M
$77M
$248M
2021
$260M
$38M
44.2%
14.9%
5.6%
3.6%
-$49M
$35M
$563M
2020
$157M
$19M
44.4%
13.7%
13.3%
5.5%
-$19M
$46M
$72M
2019
$108M
$19M
47.1%
16.5%
19.4%
8.7%
$8M
$14M
$58M
2018
$75M
$7M
46.2%
8.7%
12.6%
6.4%
$5M
—
$27M
2017
—
-$318000
—
—
-0.8%
-0.5%
—
—
$18M
2016
—
$1M
—
—
-42.4%
2.3%
—
—
$10M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$293M
$89M
46.0%
17.0%
4.8%
2.6%
-$71M
$341M
$969M
Mar '26
$231M
$17M
46.4%
15.6%
1.1%
0.6%
-$52M
$328M
$872M
Dec '25
$244M
$8M
40.9%
9.4%
0.5%
0.3%
$20M
$288M
$757M
Sep '25
$269M
$36M
42.0%
10.7%
2.5%
1.3%
-$16M
$287M
$1.1B
Jun '25
$215M
$30M
48.5%
14.7%
3.0%
1.5%
-$60M
$278M
$442M
Mar '25
$172M
$20M
47.9%
15.0%
2.1%
1.1%
-$11M
$227M
$457M
Dec '24
$223M
$31M
49.6%
19.7%
3.4%
1.7%
$77M
$183M
$407M
Sep '24
$204M
$31M
51.4%
21.7%
3.5%
1.7%
-$21M
$184M
$333M
Jun '24
$202M
$24M
47.8%
18.6%
2.9%
1.5%
$48M
$145M
$324M
Mar '24
$152M
$17M
52.0%
16.6%
2.2%
1.1%
-$35M
$115M
$211M
Dec '23
$170M
$18M
46.4%
13.7%
2.3%
1.2%
-$51M
$92M
$182M
Sep '23
$169M
$26M
52.5%
19.7%
3.5%
1.8%
-$46M
$80M
$207M
Jun '23
$145M
$27M
47.5%
21.0%
3.9%
2.0%
$5M
$73M
$257M
Mar '23
$74M
$7M
53.8%
11.9%
1.0%
0.5%
-$45M
$77M
$260M
Dec '22
$109M
$12M
49.6%
15.4%
1.7%
1.0%
-$71M
$77M
$248M
Sep '22
$134M
$21M
49.3%
23.7%
3.3%
1.8%
-$15M
$72M
$336M
Jun '22
$104M
$12M
42.3%
19.2%
1.9%
1.1%
-$36M
$28M
$324M
Mar '22
$42M
-$6M
46.7%
-22.1%
-0.9%
-0.5%
-$31M
$34M
$380M
Dec '21
$95M
$16M
47.8%
20.1%
2.3%
1.5%
-$40M
$35M
$563M
Sep '21
$67M
$10M
44.3%
17.6%
5.9%
2.2%
-$7M
$41M
$65M
Valuation over time
How the market has priced ACMR against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 20.7× (Mar '23) to 33.5× (Nov '26).
The price-to-sales ratio has risen from 2.1× (Mar '23) to 3.5× (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is ACMR growing its revenue and profit?
Over the past 5 years, Acm Research, Inc.'s revenue has grown 41.9% per year, and net income grown 38.0% per year. These are computed facts, not advice.
How much debt does ACMR have?
As of FY2025, Acm Research, Inc. reported $288M of total debt against $757M of cash; operating income covered interest expense 16×.
What is ACMR's profit margin?
In FY2025, gross margin was 44.4%, operating margin 12.1%, and net margin 10.4%.
What is ACMR's P/E ratio?
Acm Research, Inc.'s P/E (TTM) is 21.01 as of the 2026-11-03 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the ACMR stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 33.5× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.